drugset / Trial / NCT06469138
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
The aims of this Study were to determine: * How much of the Study Drug (bemcentinib) ends up in urine and faeces * How much of the Study Drug and its breakdown products get into the bloodstream * The breakdown products (metabolites) of the Study Drug * The safety of the Study Drug and any side effects that might be associated with it.
Timeline
- Start
- 2022-08-02
- Primary completion
- 2022-09-23
- Completion
- 2022-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemcentinib | Small molecule | 200 mg | Oral |